Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases.

Klement RJ, Allgäuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, Duma M, Ernst I, Flentje M, Ganswindt U, Hass P, Henkenberens C, Imhoff D, Kahl HK, Krempien R, Lohaus F, Nestle U, Nevinny-Stickel M, Petersen C, Schmitt V, Semrau S, Sterzing F, Streblow J, Wendt TG, Wittig A, Guckenberger M.

Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):841-9. doi: 10.1016/j.ijrobp.2015.12.004. Epub 2015 Dec 15.

PMID:
26972657
2.

Intra-individual comparison of 68Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer.

Giesel FL, Sterzing F, Schlemmer HP, Holland-Letz T, Mier W, Rius M, Afshar-Oromieh A, Kopka K, Debus J, Haberkorn U, Kratochwil C.

Eur J Nucl Med Mol Imaging. 2016 Mar 14. [Epub ahead of print]

PMID:
26971788
3.

Interactive dose shaping part 2: proof of concept study for six prostate patients.

Ph Kamerling C, Ziegenhein P, Sterzing F, Oelfke U.

Phys Med Biol. 2016 Mar 21;61(6):2471-84. doi: 10.1088/0031-9155/61/6/2471. Epub 2016 Mar 7.

PMID:
26948274
4.

Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy.

Thieke C, Nicolay NH, Sterzing F, Hoffmann H, Roeder F, Safi S, Debus J, Huber PE.

Radiat Oncol. 2015 Dec 30;10:267. doi: 10.1186/s13014-015-0575-5.

5.

Intensity-modulated radiotherapy versus proton radiotherapy versus carbon ion radiotherapy for spinal bone metastases: a treatment planning study.

Rief H, Chaudhri N, Tonndorf-Martini E, Bruckner T, Rieken S, Bostel T, Förster R, Schlampp I, Debus J, Sterzing F.

J Appl Clin Med Phys. 2015 Nov 8;16(6):5618.

PMID:
26699573
6.

Helical intensity-modulated radiotherapy of the pelvic lymph nodes with a simultaneous integrated boost to the prostate--first results of the PLATIN 1 trial.

Habl G, Katayama S, Uhl M, Kessel KA, Edler L, Debus J, Herfarth K, Sterzing F.

BMC Cancer. 2015 Nov 7;15:868. doi: 10.1186/s12885-015-1886-5.

7.

(68)Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients.

Sterzing F, Kratochwil C, Fiedler H, Katayama S, Habl G, Kopka K, Afshar-Oromieh A, Debus J, Haberkorn U, Giesel FL.

Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):34-41. doi: 10.1007/s00259-015-3188-1. Epub 2015 Sep 25.

8.

Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy.

Guckenberger M, Klement RJ, Allgäuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, Duma M, Ernst I, Ganswindt U, Hass P, Henkenberens C, Holy R, Imhoff D, Kahl HK, Krempien R, Lohaus F, Nestle U, Nevinny-Stickel M, Petersen C, Semrau S, Streblow J, Wendt TG, Wittig A, Flentje M, Sterzing F.

Radiother Oncol. 2016 Mar;118(3):485-91. doi: 10.1016/j.radonc.2015.09.008. Epub 2015 Sep 15.

PMID:
26385265
9.

PSMA PET/CT with Glu-urea-Lys-(Ahx)-[⁶⁸Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer.

Giesel FL, Fiedler H, Stefanova M, Sterzing F, Rius M, Kopka K, Moltz JH, Afshar-Oromieh A, Choyke PL, Haberkorn U, Kratochwil C.

Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1794-800. doi: 10.1007/s00259-015-3106-6. Epub 2015 Jul 11.

10.

The application of metal artifact reduction (MAR) in CT scans for radiation oncology by monoenergetic extrapolation with a DECT scanner.

Schwahofer A, Bär E, Kuchenbecker S, Grossmann JG, Kachelrieß M, Sterzing F.

Z Med Phys. 2015 Dec;25(4):314-25. doi: 10.1016/j.zemedi.2015.05.004. Epub 2015 Jul 3.

PMID:
26144602
11.

Accelerated tomotherapy delivery with TomoEdge technique.

Katayama S, Haefner MF, Mohr A, Schubert K, Oetzel D, Debus J, Sterzing F.

J Appl Clin Med Phys. 2015 Mar 8;16(2):4964. doi: 10.1120/jacmp.v16i2.4964.

PMID:
26103170
12.

High-dose single-fraction IMRT versus fractionated external beam radiotherapy for patients with spinal bone metastases: study protocol for a randomized controlled trial.

Rief H, Katayama S, Bruckner T, Rieken S, Bostel T, Förster R, Schlampp I, Wolf R, Debus J, Sterzing F.

Trials. 2015 Jun 9;16:264. doi: 10.1186/s13063-015-0761-7.

13.

Real-time markerless lung tumor tracking in fluoroscopic video: Handling overlapping of projected structures.

Teske H, Mercea P, Schwarz M, Nicolay NH, Sterzing F, Bendl R.

Med Phys. 2015 May;42(5):2540-9. doi: 10.1118/1.4917480.

PMID:
25979046
14.

Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy.

Haefner MF, Lang K, Krug D, Koerber SA, Uhlmann L, Kieser M, Debus J, Sterzing F.

J Radiat Res. 2015 Jul;56(4):742-9. doi: 10.1093/jrr/rrv022. Epub 2015 Apr 23.

15.

[Salvage surgery in esophageal cancer : Feasibility in patients after definitive radiochemotherapy (> 50 Gy)].

Schmidt T, Sisic L, Sterzing F, Haag GM, Kunzmann R, Grenacher L, Weichert W, Jäger D, Büchler MW, Ott K.

Chirurg. 2015 Oct;86(10):955-62. doi: 10.1007/s00104-014-2971-z. German.

PMID:
25715974
16.

Influence of human papillomavirus and p16(INK4a) on treatment outcome of patients with anal cancer.

Koerber SA, Schoneweg C, Slynko A, Krug D, Haefner MF, Herfarth K, Debus J, Sterzing F, von Knebel Doeberitz M, Prigge ES, Reuschenbach M.

Radiother Oncol. 2014 Dec;113(3):331-6. doi: 10.1016/j.radonc.2014.11.013. Epub 2014 Nov 22.

17.

In vivo measurement of dose distribution in patients' lymphocytes: helical tomotherapy versus step-and-shoot IMRT in prostate cancer.

Zwicker F, Swartman B, Roeder F, Sterzing F, Hauswald H, Thieke C, Weber KJ, Huber PE, Schubert K, Debus J, Herfarth K.

J Radiat Res. 2015 Mar;56(2):239-47. doi: 10.1093/jrr/rru096. Epub 2014 Oct 31.

18.

Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients.

Sterzing F, Hoehle F, Ulrich A, Jensen A, Debus J, Muenter M.

J Radiat Res. 2015 Jan;56(1):169-76. doi: 10.1093/jrr/rru089. Epub 2014 Oct 23.

19.

Hypofractionated IMRT of the prostate bed after radical prostatectomy: acute toxicity in the PRIAMOS-1 trial.

Katayama S, Striecker T, Kessel K, Sterzing F, Habl G, Edler L, Debus J, Herfarth K.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):926-33. doi: 10.1016/j.ijrobp.2014.07.015. Epub 2014 Sep 9.

PMID:
25216858
20.

Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis.

Schanne DH, Nestle U, Allgäuer M, Andratschke N, Appold S, Dieckmann U, Ernst I, Ganswindt U, Grosu AL, Holy R, Molls M, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Guckenberger M.

Strahlenther Onkol. 2015 Feb;191(2):125-32. doi: 10.1007/s00066-014-0739-5. Epub 2014 Aug 27.

PMID:
25159135
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk